Croca, S;
Rahman, A;
(2017)
Atherosclerosis in systemic lupus erythematosus.
Best Practice & Research Clinical Rheumatology
, 31
(3)
pp. 364-372.
10.1016/j.berh.2017.09.012.
Preview |
Text
Rahman_YBERH_1274_edit_report_redacted.pdf - Accepted Version Download (108kB) | Preview |
Abstract
Cardiovascular disease (CVD), comprising coronary heart disease and stroke, is one of the most important causes of death in patients with systemic lupus erythematosus (SLE). The risks of developing both clinical CVD and sub-clinical atherosclerosis are increased in patients with SLE. This increase is not fully explained by traditional cardiovascular risk factors such as smoking, hypertension and elevated cholesterol, and it is believed that immune dysfunction also contributes to CVD risk in SLE. In particular, recent studies have shown that abnormalities in both serum lipid profile and the autoantibody and T lymphocyte response to lipids may play a role in development of atherosclerosis. The standard CVD risk calculation algorithms based on traditional risk factors underestimate the risk of developing CVD in patients with SLE. Thus, novel algorithms incorporating new biomarkers such as pro-inflammatory high-density lipoprotein and use of imaging techniques such as carotid ultrasound scanning may become increasingly valuable.
Type: | Article |
---|---|
Title: | Atherosclerosis in systemic lupus erythematosus |
Location: | Netherlands |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.berh.2017.09.012 |
Publisher version: | http://dx.doi.org/10.1016/j.berh.2017.09.012 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | Atherosclerosis, Autoantibodies, Cardiovascular disease, Invariant natural killer T cells, Lipids, Risk stratification, Systemic lupus erythematosus |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
URI: | https://discovery.ucl.ac.uk/id/eprint/10035122 |
Archive Staff Only
View Item |